0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-7252.94%PremiumDec 20, 2024Expiry Date2.47Intrinsic Value100Multiplier16DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.01Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Galera Therapeutics Stock Discussion
Item 5.07.Submission of Matters to a Vote of Security Holders.
On October 17, 2024, Galera Therapeutics, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). A total of 32,061,280 shares of common stock were present online or represented by proxy at the Special Meeting, representing approximately 58.94% percent of the Company’s outstanding common stock as of the August 27, 2024 record ...
Galera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-ALPHA PHARMA INVESTMENTS LLC - EIN:(5.056%)
No comment yet